EPA-Approved SARS-CoV-2 Disinfectants
7 rows where Contact_time = "4.0" and Why_on_List_N = "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim"
json
Export this Data | Chart Risk Level by Product
Clear Chart
Add More Filters: Active_ingredient, Formulation_type,
Why_on_List_N
✖
- Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim · 7 ✖
ID ▼
|
EPA_reg_num
|
Risk_level
|
Active_ingredient
|
Product_name
|
Company
|
Use_site
|
Surface_type
|
Contact_time
|
Formulation_type
|
Follow_directions_for_this_virus
|
Date_on_List_N
|
Why_on_List_N
|
1091 |
6836-340 |
Increased Risk |
Quaternary ammonium |
Lonza Disinfectant Wipes Plus 2 |
Arxada, LLC |
Healthcare; Institutional |
Hard Nonporous (HN) |
4.0 minutes |
Wipe |
SARS-CoV-2 |
2020-08-07 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1095 |
6836-336 |
Increased Risk |
Quaternary ammonium |
Lonza Disinfectant Wipes Plus |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
4.0 minutes |
Wipe |
SARS-CoV-2 |
2020-08-06 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1096 |
6836-382 |
Increased Risk |
Quaternary ammonium |
Nugen Low Streak Disinfectant Wipes |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
4.0 minutes |
Wipe |
SARS-CoV-2 |
2020-08-06 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1097 |
6836-313 |
Increased Risk |
Quaternary ammonium |
Lonza Disinfectant Wipes |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
4.0 minutes |
Wipe |
SARS-CoV-2 |
2020-08-06 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1494 |
71847-7 |
Increased Risk |
Sodium dichloroisocyanurate |
Klorkleen |
Medentech LTD |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
4.0 minutes |
Dilutable; Electrostatic Spray |
SARS-CoV-2 |
2021-01-28 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1701 |
6836-445 |
Increased Risk |
PHMB; Quaternary ammonium |
Nugen NR RTU |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
4.0 minutes |
Ready-to-use |
SARS-CoV-2 |
2021-02-11 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1702 |
6836-446 |
Increased Risk |
PHMB; Quaternary ammonium |
Nugen NR-128 |
Arxada, LLC |
Healthcare; Institutional; Residential |
Hard Nonporous (HN) |
4.0 minutes |
Dilutable |
SARS-CoV-2 |
2021-02-11 |
Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |